BioAdaptives (BDPT) Stock Price

BioAdaptives Price

OTC·CLOSED
0.00
​
Market closed

Revenue at BioAdaptives has contracted by 0.5% per year over the past 9 years to 18,278.00 USD. BioAdaptives's net margin stands at -8,523.4%, down from -5,309.5% several years earlier.

BioAdaptives stock price

Access this data via the Eulerpool API

BioAdaptives business model & stock analysis

BioAdaptives, Inc. is a research, development, marketing and educational company. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2014-07-09. The firm is focused on products for health and wellness. These products include dietary supplements, specialty food items, and methods of optimizing the bioelectromagnetic availability of foods and beverages. Its base of intellectual property and products, which are solutions in the form of devices and nutraceuticals, are designed to aid in cognition, focus, fatigue reduction, increased testosterone, improved overall emotional and physical wellness, healing, and anti-aging. The firm has a product agreement with Ferris Holding, Inc. (Ferris), pursuant to which it has the right to develop, market and sell the products, including PrimiCell and PrimiLive. Additionally, it has two products, which are in the advanced stage of testing: Equine Regen and Equine Regen Plus. The firm also offers PrimiTrim, which is a weight control product, and an exercise product. The company is also developing a product for dogs.

Frequently asked questions about BioAdaptives

Converted at the current exchange rate, the BioAdaptives share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for BioAdaptives.

The profit cannot currently be calculated for BioAdaptives.

The P/E ratio cannot be calculated for BioAdaptives at the moment.

The P/S cannot be calculated for BioAdaptives currently.

The Eulerpool Quality Score for BioAdaptives is 3/10.

The ISIN of BioAdaptives is US09072U2069. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of BioAdaptives is A1XCCG. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of BioAdaptives is BDPT. The ticker symbol is used to trade BioAdaptives shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
18,278.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jul 9, 2014
ISIN
US09072U2069
Cusip
09072U107
Sedol
BP456T6
Market capitalization
12,323.10 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
3.52
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
89.25 %
Last updated Oct 10, 2026, 4:47 PM

BioAdaptives Peer Group

BioAdaptives Ticker

OTC · BDPTOTC · BDPT